Glaxo in Trouble over Claims Against Avandia Diabetes Drug

.

Glaxo in Trouble over Claims Against Avandia Diabetes Drug

There have been claims that Avandia diabetes drug is causing high risk of heart attacks and congestive heart failure to the users. And in this regard, around four Lawsuits have been filed in the UK against the producer, GlaxoSmithKline Plc (GSK).

Avandia was once known as the world's best diabetes pill but now has been surrounded amid several claims.

Daniel Slade is the lawyer involved and he is representing consumers in four lawsuits. In addition, there are 15 more clients in his list of this case. As revealed by him, the potential number of claims against GSK seems to go higher in a short period of time.

He commented during a telephonic interview: "We expect the number of claims to increase as there are potentially thousands of people out there who took Avandia in the U. K. Hopefully these claims will lead to more careful studies and checks on drugs that are widely marketed".

To settle down the claims of marketing Avandia along with other medication in an illegal manner; Glaxo had already paid more than $3 billion to the U. S. federal and state government.

David Daley, a spokesman for Brentford, UK-based Glaxo, while sympathizing with people suffering from health complications related with diabetes said that the company is bound to comment over any such cases.

 


Latest News

Taco Bell’s Mystery Food comes to Town; “Quesalupa’ Introduced in Super Bowl Sun
Chipotle will Shutter Restaurants on Monday for Four Hours for Food Safety Meeti
China’s Sluggish Growth, Drop in Commodity Prices makes Markets Unsure about Pol
U.S Job Growth and Increase in Average Hourly Wages Brings Optimism
Weaker Economic Data May Continue Dovish Outlook
Texas Supermarket Chain HEB Recalls its Ice cream Flavor due to Possible Presenc
New $6 million scanner installed at Royal Children's Hospital in Melbourne
Experts assure lettuce sold in supermarket is safe
Oil Prices Drop Due to Volatile Trade; Sunday’s Meeting between Key Producers Ke
Chinese Investors of eZubao Face $7.6 Billion Worth Losses
HEB Recalls One of Its Ice Cream Flavor Voluntarily
Average U.S. Unemployment Rate Drops and Wages Rise